Modera Wealth Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
RJFSA
BFG
RJA
Modera Wealth Management's FBT Position: Q1 2022 in Review
Modera Wealth Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2022, closing a stake of 1,271 shares — an estimated $206K sold.
Modera Wealth Management first reported a position in FBT in Q1 2016 and held it in 21 quarters. The position peaked at $267K in Q3 2018. 219 funds tracked by Wall St. Rank hold FBT as of Q1 2022.
- Modera Wealth Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2022 after selling out during the quarter.
- Modera Wealth Management sold 1,271 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2022, an estimated $206K.
- Modera Wealth Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2016 and held it in 21 quarters.
- Modera Wealth Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $267K in Q3 2018.
- 219 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2022.
Based on Modera Wealth Management's 13F filing for Q1 2022, filed 3 May 2022.